Charles River Laboratories International (CRL) P/E ratio

P/E ratio today
361.0×

Charles River Laboratories International (CRL) trades at 361.0× its earnings per share over the last twelve months. At the end of fiscal 2023 (December 31, 2023) its P/E ratio was 25.6×. That is 11.5% higher than the 23.0× of fiscal 2022. Figures as of 18 Nov 2026, 06:44 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
361.0×
P/E ratio, fiscal 2023
25.6×
Change on fiscal 2022
+11.5%
Highest on record
49.6×fiscal 2021
Lowest on record
12.8×fiscal 2011
Fiscal years on record
142009–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Charles River Laboratories International P/E ratio, in more detail

Today's figure is 1308.1% above the fiscal 2023 year-end.

Across the 14 fiscal year-ends on record (2009–2023), the highest was 49.6× in fiscal 2021 and the lowest 12.8× in fiscal 2011. Today's P/E ratio is above every one of the 14 fiscal year-ends on record; their median is 24.8×.

History · 14 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Charles River Laboratories International P/E ratio, year by year

Charles River Laboratories International (CRL) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today361.0×—$332.16—
2025——$199.48-$2.91
2024——$184.60$0.20
202325.6× 11.5% up$236.40$9.22
202223.0× 53.6% down$217.90$9.48
202149.6× 42.9% up$376.78$7.60
202034.7× 15.2% up$249.86$7.20
201930.1× 23.0% up$152.76$5.07
201824.5× 43.1% down$113.18$4.62
201743.1× 82.7% up$109.45$2.54
201623.6× 8.2% down$76.19$3.23
201525.7× 7.4% up$80.39$3.13
201423.9× 4.4% down$63.64$2.66
201325.0× 34.2% up$53.04$2.12
201218.6× 46.0% up$37.47$2.01
201112.8×—$27.33$2.14
2010——$35.54-$5.38
200919.4×—$33.69$1.74
2008——$26.20-$7.80

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Charles River Laboratories International and comparable companies
CompanyP/E ratio
Medpace Holdings MEDP36.3×
Revvity RVTY65.7×
Exelixis EXEL20.5×
Charles River Laboratories International CRL361.0×
Neurocrine Biosciences NBIX24.6×
Ascendis Pharma ASND17.9×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on CRL

Charles River Laboratories International, figure by figure

Charles River Laboratories International (CRL) overview: price, valuation and scorecardAll health care companies by market value

Charles River Laboratories International P/E ratio: questions and answers

What is Charles River Laboratories International's P/E ratio?

Charles River Laboratories International (CRL) trades at 361.0× its earnings per share over the last twelve months. At the end of fiscal 2023 (December 31, 2023) its P/E ratio was 25.6×. That is 11.5% higher than the 23.0× of fiscal 2022.

Is Charles River Laboratories International's P/E ratio high or low compared with its own history?

Today's P/E ratio is above every one of the 14 fiscal year-ends on record; their median is 24.8×.

What are the highest and lowest P/E ratio figures on record for Charles River Laboratories International?

Across the 14 fiscal year-ends on record (2009–2023), the highest was 49.6× in fiscal 2021 and the lowest 12.8× in fiscal 2011.

How is Charles River Laboratories International's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Charles River Laboratories International (CRL) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/CRL/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.